The Influence of the Neuromuscular Blockade on Mask Ventilation; a Placebo Controlled, Randomized Trial With Three Different Dosages of Rocuronium (0.3 mg/kg, 0.6 mg/kg and 0.9 mg/kg)
Phase of Trial: Phase II
Latest Information Update: 04 May 2016
At a glance
- Drugs Rocuronium bromide (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 02 May 2016 Status changed from recruiting to completed.
- 21 Oct 2015 Planned End Date changed from 1 Jan 2016 to 1 Mar 2016 as reported by ClinicalTrials.gov record.
- 21 Oct 2015 Planned primary completion date changed from 1 Jan 2016 to 1 Mar 2016 as reported by ClinicalTrials.gov record.